Large-Cap
Netflix Shifts Warner Bros. Bid to All-Cash Deal, Raising Stakes in Hollywood Takeover Fight
Revised $27.75-per-share offer aims to boost certainty for investors and accelerate a shareholder vote as Paramount pressure grows. Netflix (NFLX)...
GSK to Acquire RAPT Therapeutics for $2.2 Billion, Strengthening Its Immunology Pipeline
Deal delivers global rights to experimental food allergy therapy ozureprubart as GSK pursues growth under new CEO Luke Miels. Britain’s...
ASML Joins Europe’s $500 Billion Elite as AI Spending Accelerates
Record rally underscores ASML’s central role in the global semiconductor and artificial intelligence boom. ASML Holding NV (ASML) has crossed...
Bitcoin Rebounds, Lifting MicroStrategy and Coinbase Amid Market Strength
Bitcoin’s renewed upside drives gains in crypto equities, though broader volatility still looms. Bitcoin (BTC) climbed notably today, trading near...
Google Joins the $4 Trillion Club as AI Boom Rewrites Big Tech’s Power Rankings
Surging Gemini adoption and custom chip deals propel Alphabet into rarefied territory—just behind Nvidia. Google has officially entered one of...
Paramount Skydance Escalates Showdown for Warner Bros. in High-Stakes Streaming War
Legal action, boardroom battles, and a rival Netflix bid push Hollywood’s biggest takeover fight to a breaking point. The battle...
UnitedHealth’s Road to $500: Why the Healthcare Giant Could Rally Over the Next 12–14 Months
From turnaround strategies to long-term growth drivers, UNH may be poised for a powerful rebound as market sentiment shifts UnitedHealth...
Alumis Breaks Out With Promising Psoriasis Data
Envudeucitinib positions the biotech for a high-stakes TYK2 showdown heading into 2026 Biotech stock Alumis (ALMS) surged more than 110%...
Lithium’s Comeback: Why Albemarle Could Be Poised for a Strong 2026
Rising energy storage demand and tightening supply signal a potential cyclical upturn for lithium markets Lithium prices are showing renewed...
Five Stock Ideas Kicking Off 2026 as Markets Keep Chasing “More”
Top strategists weigh in on AI, valuation discipline, and where opportunity may still exist After a powerful 2025 that delivered...
